C.M. Bidwell & Associates’s Veradigm Inc. Common Stock MDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MDRX
C.M. Bidwell & Associates's MDRX Position: Q1 2023 in Review
C.M. Bidwell & Associates sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2023, closing a stake of 2,195 shares — an estimated $38.7K sold.
C.M. Bidwell & Associates first reported a position in MDRX in Q2 2019 and held it in 7 quarters. The position peaked at $44K in Q1 2022. 242 funds tracked by Wall St. Rank hold MDRX as of Q1 2023.
- C.M. Bidwell & Associates reported no remaining Veradigm Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- C.M. Bidwell & Associates sold 2,195 Veradigm Inc. Common Stock shares in Q1 2023, an estimated $38.7K.
- C.M. Bidwell & Associates first reported a position in Veradigm Inc. Common Stock in Q2 2019 and held it in 7 quarters.
- C.M. Bidwell & Associates's Veradigm Inc. Common Stock position peaked at $44K in Q1 2022.
- 242 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2023.
Based on C.M. Bidwell & Associates's 13F filing for Q1 2023, filed 12 May 2023.